Explore › Condition › Mild bronchopulmonary dysplasia of newborn
Condition

Mild bronchopulmonary dysplasia of newborn

Also known as: Mild bronchopulmonary dysplasia of newborn Mild bronchopulmonary dysplasia of newborn (disorder) bronchopulmonary dysplasia; intraventricular hemorrhage or periventricular leukomalacia; necrotizing enterocolitis
3 findings 1 paper 4 related entities View in graph →

Related entities

interventions
History of gastrostomy tube placement1
outcomes
Association1
populations
Children1
studys
PMC68157001

Findings (27)

None
decline

Bronchopulmonary dysplasia was the strongest neonatal comorbidity associated with gastrostomy tube placement in ELBW infants, with nearly 3-fold increased adjusted odds after controlling for center an

Effect: decline; OR 2.94; CI: 95% CI 2.20-3.92

Size: OR 2.94 CI: 95% CI 2.20-3.92
PMC6815700
Finding details → · Paper → · Graph →
None
decline

Bronchopulmonary dysplasia was the strongest neonatal comorbidity associated with gastrostomy tube placement in ELBW infants, with nearly 3-fold increased adjusted odds after controlling for center an

Effect: decline; OR 2.94; CI: 95% CI 2.20-3.92

Size: OR 2.94 CI: 95% CI 2.20-3.92
PMC6815700
Finding details → · Paper → · Graph →
None
decline

Bronchopulmonary dysplasia was the strongest neonatal comorbidity associated with gastrostomy tube placement in ELBW infants, with nearly 3-fold increased adjusted odds after controlling for center an

Effect: decline; OR 2.94; CI: 95% CI 2.20-3.92

Size: OR 2.94 CI: 95% CI 2.20-3.92
PMC6815700
Finding details → · Paper → · Graph →
None
decline

Bronchopulmonary dysplasia was the strongest neonatal comorbidity associated with gastrostomy tube placement in ELBW infants, with nearly 3-fold increased adjusted odds after controlling for center an

Effect: decline; OR 2.94; CI: 95% CI 2.20-3.92

Size: OR 2.94 CI: 95% CI 2.20-3.92
PMC6815700
Finding details → · Paper → · Graph →
None
decline

Bronchopulmonary dysplasia was the strongest neonatal comorbidity associated with gastrostomy tube placement in ELBW infants, with nearly 3-fold increased adjusted odds after controlling for center an

Effect: decline; OR 2.94; CI: 95% CI 2.20-3.92

Size: OR 2.94 CI: 95% CI 2.20-3.92
PMC6815700
Finding details → · Paper → · Graph →
None
decline

Bronchopulmonary dysplasia was the strongest neonatal comorbidity associated with gastrostomy tube placement in ELBW infants, with nearly 3-fold increased adjusted odds after controlling for center an

Effect: decline; OR 2.94; CI: 95% CI 2.20-3.92

Size: OR 2.94 CI: 95% CI 2.20-3.92
PMC6815700
Finding details → · Paper → · Graph →
None
decline

Bronchopulmonary dysplasia was the strongest neonatal comorbidity associated with gastrostomy tube placement in ELBW infants, with nearly 3-fold increased adjusted odds after controlling for center an

Effect: decline; OR 2.94; CI: 95% CI 2.20-3.92

Size: OR 2.94 CI: 95% CI 2.20-3.92
PMC6815700
Finding details → · Paper → · Graph →
None
decline

Bronchopulmonary dysplasia was the strongest neonatal comorbidity associated with gastrostomy tube placement in ELBW infants, with nearly 3-fold increased adjusted odds after controlling for center an

Effect: decline; OR 2.94; CI: 95% CI 2.20-3.92

Size: OR 2.94 CI: 95% CI 2.20-3.92
PMC6815700
Finding details → · Paper → · Graph →
None
decline

Bronchopulmonary dysplasia was the strongest neonatal comorbidity associated with gastrostomy tube placement in ELBW infants, with nearly 3-fold increased adjusted odds after controlling for center an

Effect: decline; OR 2.94; CI: 95% CI 2.20-3.92

Size: OR 2.94 CI: 95% CI 2.20-3.92
PMC6815700
Finding details → · Paper → · Graph →
None
decline

Bronchopulmonary dysplasia was the strongest neonatal comorbidity associated with gastrostomy tube placement in ELBW infants, with nearly 3-fold increased adjusted odds after controlling for center an

Effect: decline; OR 2.94; CI: 95% CI 2.20-3.92

Size: OR 2.94 CI: 95% CI 2.20-3.92
PMC6815700
Finding details → · Paper → · Graph →
None
decline

Bronchopulmonary dysplasia was the strongest neonatal comorbidity associated with gastrostomy tube placement in ELBW infants, with nearly 3-fold increased adjusted odds after controlling for center an

Effect: decline; OR 2.94; CI: 95% CI 2.20-3.92

Size: OR 2.94 CI: 95% CI 2.20-3.92
PMC6815700
Finding details → · Paper → · Graph →
None
decline

Bronchopulmonary dysplasia was the strongest neonatal comorbidity associated with gastrostomy tube placement in ELBW infants, with nearly 3-fold increased adjusted odds after controlling for center an

Effect: decline; OR 2.94; CI: 95% CI 2.20-3.92

Size: OR 2.94 CI: 95% CI 2.20-3.92
PMC6815700
Finding details → · Paper → · Graph →
None
decline

Bronchopulmonary dysplasia was the strongest neonatal comorbidity associated with gastrostomy tube placement in ELBW infants, with nearly 3-fold increased adjusted odds after controlling for center an

Effect: decline; OR 2.94; CI: 95% CI 2.20-3.92

Size: OR 2.94 CI: 95% CI 2.20-3.92
PMC6815700
Finding details → · Paper → · Graph →
None
decline

Bronchopulmonary dysplasia was the strongest neonatal comorbidity associated with gastrostomy tube placement in ELBW infants, with nearly 3-fold increased adjusted odds after controlling for center an

Effect: decline; OR 2.94; CI: 95% CI 2.20-3.92

Size: OR 2.94 CI: 95% CI 2.20-3.92
PMC6815700
Finding details → · Paper → · Graph →
None
decline

Bronchopulmonary dysplasia was the strongest neonatal comorbidity associated with gastrostomy tube placement in ELBW infants, with nearly 3-fold increased adjusted odds after controlling for center an

Effect: decline; OR 2.94; CI: 95% CI 2.20-3.92

Size: OR 2.94 CI: 95% CI 2.20-3.92
PMC6815700
Finding details → · Paper → · Graph →
None
decline

Bronchopulmonary dysplasia was the strongest neonatal comorbidity associated with gastrostomy tube placement in ELBW infants, with nearly 3-fold increased adjusted odds after controlling for center an

Effect: decline; OR 2.94; CI: 95% CI 2.20-3.92

Size: OR 2.94 CI: 95% CI 2.20-3.92
PMC6815700
Finding details → · Paper → · Graph →
None
decline

Bronchopulmonary dysplasia was the strongest neonatal comorbidity associated with gastrostomy tube placement in ELBW infants, with nearly 3-fold increased adjusted odds after controlling for center an

Effect: decline; OR 2.94; CI: 95% CI 2.20-3.92

Size: OR 2.94 CI: 95% CI 2.20-3.92
PMC6815700
Finding details → · Paper → · Graph →
None
decline

Bronchopulmonary dysplasia was the strongest neonatal comorbidity associated with gastrostomy tube placement in ELBW infants, with nearly 3-fold increased adjusted odds after controlling for center an

Effect: decline; OR 2.94; CI: 95% CI 2.20-3.92

Size: OR 2.94 CI: 95% CI 2.20-3.92
PMC6815700
Finding details → · Paper → · Graph →
None
decline

Bronchopulmonary dysplasia was the strongest neonatal comorbidity associated with gastrostomy tube placement in ELBW infants, with nearly 3-fold increased adjusted odds after controlling for center an

Effect: decline; OR 2.94; CI: 95% CI 2.20-3.92

Size: OR 2.94 CI: 95% CI 2.20-3.92
PMC6815700
Finding details → · Paper → · Graph →
None
decline

Bronchopulmonary dysplasia was the strongest neonatal comorbidity associated with gastrostomy tube placement in ELBW infants, with nearly 3-fold increased adjusted odds after controlling for center an

Effect: decline; OR 2.94; CI: 95% CI 2.20-3.92

Size: OR 2.94 CI: 95% CI 2.20-3.92
PMC6815700
Finding details → · Paper → · Graph →
None
decline

Bronchopulmonary dysplasia was the strongest neonatal comorbidity associated with gastrostomy tube placement in ELBW infants, with nearly 3-fold increased adjusted odds after controlling for center an

Effect: decline; OR 2.94; CI: 95% CI 2.20-3.92

Size: OR 2.94 CI: 95% CI 2.20-3.92
PMC6815700
Finding details → · Paper → · Graph →
None
decline

Bronchopulmonary dysplasia was the strongest neonatal comorbidity associated with gastrostomy tube placement in ELBW infants, with nearly 3-fold increased adjusted odds after controlling for center an

Effect: decline; OR 2.94; CI: 95% CI 2.20-3.92

Size: OR 2.94 CI: 95% CI 2.20-3.92
PMC6815700
Finding details → · Paper → · Graph →
None
decline

Bronchopulmonary dysplasia was the strongest neonatal comorbidity associated with gastrostomy tube placement in ELBW infants, with nearly 3-fold increased adjusted odds after controlling for center an

Effect: decline; OR 2.94; CI: 95% CI 2.20-3.92

Size: OR 2.94 CI: 95% CI 2.20-3.92
PMC6815700
Finding details → · Paper → · Graph →
None
decline

Bronchopulmonary dysplasia was the strongest neonatal comorbidity associated with gastrostomy tube placement in ELBW infants, with nearly 3-fold increased adjusted odds after controlling for center an

Effect: decline; OR 2.94; CI: 95% CI 2.20-3.92

Size: OR 2.94 CI: 95% CI 2.20-3.92
PMC6815700
Finding details → · Paper → · Graph →
None
decline

Bronchopulmonary dysplasia was the strongest neonatal comorbidity associated with gastrostomy tube placement in ELBW infants, with nearly 3-fold increased adjusted odds after controlling for center an

Effect: decline; OR 2.94; CI: 95% CI 2.20-3.92

Size: OR 2.94 CI: 95% CI 2.20-3.92
PMC6815700
Finding details → · Paper → · Graph →
None
decline

Bronchopulmonary dysplasia was the strongest neonatal comorbidity associated with gastrostomy tube placement in ELBW infants, with nearly 3-fold increased adjusted odds after controlling for center an

Effect: decline; OR 2.94; CI: 95% CI 2.20-3.92

Size: OR 2.94 CI: 95% CI 2.20-3.92
PMC6815700
Finding details → · Paper → · Graph →
None
decline

Bronchopulmonary dysplasia was the strongest neonatal comorbidity associated with gastrostomy tube placement in ELBW infants, with nearly 3-fold increased adjusted odds after controlling for center an

Effect: decline; OR 2.94; CI: 95% CI 2.20-3.92

Size: OR 2.94 CI: 95% CI 2.20-3.92
PMC6815700
Finding details → · Paper → · Graph →

Papers (1)